Chase Pattison

Chase Pattison is the Chief Commercial Officer at Genomind, overseeing the nation's leading medication management platform since September 2024. Prior to this role, Chase served as Senior Vice President of Marketing and Sales Operations at IVX Health, enhancing infusion and injection therapy services from July 2018 to September 2024. Experience also includes positions as Vice President of Marketing at NextGen Healthcare and Chief Marketing & Commercial Officer at Entrada, Inc., which was acquired by NextGen. Earlier career roles encompass various marketing and business development positions at Uloop, FiledBy, ECHO Music, Griffin Technology, Accelerator at Vanderbilt Summer Business Institute, and BOHAN Advertising. Chase holds an MBA in Brand Management from Vanderbilt University and a Bachelor of Science in Business Administration with a focus on Marketing from the University of Tennessee, Knoxville.